Study population | Treatment decision | Study design | Quality of studies** | |||
---|---|---|---|---|---|---|
Number (gender) | Age (mean) (range) | Patient population | Data collection | |||
Preference prospectively measured | ||||||
Brown et al., 2012 USA [15] | 683 women | 55.3 | Breast cancer | General | RCT questionnaire before and after consultation | 3 |
- | ||||||
Butow et al., 2004 Australia [29] | 75 men | 58 | Cancer | General | RCT Questionnaires before and after consultation | 3 |
89 women | - | |||||
Clayton et al., 2011 USA [32] | 62 men | 43.2 | Patients from general practice | General | self-reported data | 2 |
107 women | 18-89 | |||||
Davison and Degner, 2002 Canada [31] | 749 women | 58.3 | Breast cancer | General | Prospective, blocked, two-arm randomized controlled trial | 1 |
- | ||||||
Degner et al., 1997 Canada [12] | 1012 women | - | Breast cancer | Operation | Cross-sectional, consecutive sampling, nurse administrated questionnaire | 3 |
58.3 | ||||||
Ernst et al., 2010 Germany [17] | 59 men | 57 | Hemato-oncological illnesses | General | Postal review interview | 1 |
45 women | 21-84 | |||||
Gattellari et al., 2001 Australia [27] | 133 men | 56.7 | Cancer | General | RCT prospective, cross-sectional consecutive sampling self-administered questionnaire | 4 |
100 women | 22-82 | |||||
Janz et al., 2004 USA [26] | 101 women | 54.9 | Breast cancer | Operation | Telephone interviews | 4 |
34-81 | ||||||
Kasper et al., 2008 Germany [30] | 79 men | 43.1 | MS | Medication | RCT; telephone and post, standardized questionnaires | 4 |
218 women | - | |||||
Leighl et al., 2011 Canada [24] | 62 men | 62.5 | Colorectal cancer | Medication | RCT | 2 |
38 women | - | |||||
Ramfelt et al., 2000 Sweden [25] | 41 men | 70 | Colorectal cancer | Operation | Questionnaires | 3 |
45 women | 34-84 | |||||
Wunderlich et al., 2010 USA [28] | 134 men | 58 | Colorectal cancer | Screening | Pre- and post-visit survey | 1 |
229 women | - |